Arcturus Therapeutics
ARCT
#8663
Rank
โ‚ฌ0.17 B
Marketcap
6,17ย โ‚ฌ
Share price
1.92%
Change (1 day)
-42.72%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -โ‚ฌ68.32 Million

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ85.14 Million. In 2024 the company made an earning of -โ‚ฌ79.57 Million a decrease over its 2023 earnings that were of -โ‚ฌ23.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ68.32 Million-14.14%
2024 -โ‚ฌ79.57 Million240.24%
2023 -โ‚ฌ23.39 Million-298.78%
2022 โ‚ฌ11.76 M-106.79%
2021 -โ‚ฌ0.18 Billion181.83%
2020 -โ‚ฌ61.5 Million183.72%
2019 -โ‚ฌ21.68 Million16.93%
2018 -โ‚ฌ18.54 Million154.5%
2017 -โ‚ฌ7.29 Million-65.36%
2016 -โ‚ฌ21.03 Million25.93%
2015 -โ‚ฌ16.7 Million-41.04%
2014 -โ‚ฌ28.33 Million219.64%
2013 -โ‚ฌ8.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.87 Million-97.12% Bahamas
NRC Health
NRC
โ‚ฌ23.77 M-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA